Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Shortec 5mg capsules
0407020ADBJAAAC
|
Shortec | Oxycodone hydrochloride | Central Nervous System | 29,740 |
|
Shortec 10mg capsules
0407020ADBJABAD
|
Shortec | Oxycodone hydrochloride | Central Nervous System | 19,301 |
|
Shortec 20mg capsules
0407020ADBJACAE
|
Shortec | Oxycodone hydrochloride | Central Nervous System | 8,281 |
|
Shortec liquid 1mg/ml oral solution
0407020ADBJAGAA
|
Shortec | Oxycodone hydrochloride | Central Nervous System | 5,514 |
|
Shortec 10mg/ml concentrate oral solution
0407020ADBJAHAB
|
Shortec | Oxycodone hydrochloride | Central Nervous System | 159 |
|
Shortec 10mg/1ml solution for injection ampoules
0407020ADBJADAL
|
Shortec | Oxycodone hydrochloride | Central Nervous System | 77 |
|
Shortec 50mg/1ml solution for injection ampoules
0407020ADBJAFAN
|
Shortec | Oxycodone hydrochloride | Central Nervous System | 14 |
|
Shortec 20mg/2ml solution for injection ampoules
0407020ADBJAEAM
|
Shortec | Oxycodone hydrochloride | Central Nervous System | 11 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.